跳至主要内容
临床试验/CTRI/2018/02/011935
CTRI/2018/02/011935已完成4 期

An Open Label, Single arm, Observational Study to Evaluate the Efficacy, Safety & Tolerability of Ketoconazole 2 % in Combination With Beclomethasone 0.025% in Patients With Tinea and sebaceous dermatitisInfections

Med Manor Organics Pvt ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subjects with tinea infections who are either treatment naive or were not on any treatment for at-least 3 months
  • 2.Have a clinical diagnosis of uncomplicated interdigital Tinea pedis confirmed by KOH microscopy
  • 3.Subjects aged 12 to 75 years with Tinea Infections
  • 4.Subjects with Epidermal type of Tinea infections
  • 5.Subjects willing to return for all clinic visits and complete all study-related procedures

排除标准

  • 1.Subjects with dermal or any other type of fungal infections other than epidermal type
  • 2.Subjects who are either pregnant or breast feeding
  • 3.Have a previous sensitivity to imidazole antifungal agents or to any ingredient of the study medication
  • 4.Subjects taking any other form of alternative treatment like ayurvedic etc.. for fungal infections
  • 5.Subjects known to have hypersensitivity to any of the ingredients of the formulation

研究者

发起方
Med Manor Organics Pvt ltd

相似试验